Financials Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse 21:00:02 14/06/2024 BST 5-day change 1st Jan Change
139.4 USD -3.30% Intraday chart for Celanese Corporation -4.83% -10.29%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,882 15,189 18,297 11,086 16,913 15,224 - -
Enterprise Value (EV) 1 18,324 17,957 21,728 24,257 28,792 26,223 24,812 23,576
P/E ratio 18 x 7.76 x 9.97 x 5.9 x 8.67 x 13.5 x 10.6 x 10.3 x
Yield 1.95% 1.91% 1.62% 2.68% 1.8% 2.02% 2.08% 2.24%
Capitalization / Revenue 2.36 x 2.69 x 2.14 x 1.15 x 1.55 x 1.39 x 1.31 x 1.25 x
EV / Revenue 2.91 x 3.18 x 2.55 x 2.51 x 2.63 x 2.39 x 2.14 x 1.94 x
EV / EBITDA 10.2 x 12.2 x 7.66 x 9.27 x 11.8 x 9.67 x 8.35 x 7.63 x
EV / FCF 16.9 x 18.3 x 16.8 x 19 x 21.8 x 20.3 x 16.3 x 13.3 x
FCF Yield 5.92% 5.45% 5.94% 5.26% 4.58% 4.92% 6.15% 7.54%
Price to Book 5.91 x 4.34 x 4.33 x 1.97 x 2.4 x 1.92 x 1.7 x 1.49 x
Nbr of stocks (in thousands) 120,874 116,895 108,871 108,428 108,855 109,220 - -
Reference price 2 123.1 129.9 168.1 102.2 155.4 139.4 139.4 139.4
Announcement Date 30/01/20 28/01/21 27/01/22 23/02/23 20/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,297 5,655 8,537 9,673 10,940 10,952 11,583 12,132
EBITDA 1 1,805 1,475 2,835 2,617 2,444 2,711 2,971 3,091
EBIT 1 1,476 1,131 2,473 2,171 1,753 1,987 2,241 2,422
Operating Margin 23.44% 20% 28.97% 22.44% 16.02% 18.14% 19.34% 19.96%
Earnings before Tax (EBT) 1 988 2,251 2,248 1,421 1,183 1,308 1,727 1,509
Net income 1 852 1,985 1,890 1,894 1,960 1,133 1,490 1,496
Net margin 13.53% 35.1% 22.14% 19.58% 17.92% 10.34% 12.86% 12.33%
EPS 2 6.840 16.75 16.86 17.34 17.92 10.35 13.11 13.60
Free Cash Flow 1 1,084 979 1,290 1,276 1,320 1,290 1,527 1,778
FCF margin 17.21% 17.31% 15.11% 13.19% 12.07% 11.78% 13.18% 14.66%
FCF Conversion (EBITDA) 60.06% 66.37% 45.5% 48.76% 54.01% 47.58% 51.39% 57.53%
FCF Conversion (Net income) 127.23% 49.32% 68.25% 67.37% 67.35% 113.85% 102.47% 118.88%
Dividend per Share 2 2.400 2.480 2.720 2.740 2.800 2.813 2.899 3.118
Announcement Date 30/01/20 28/01/21 27/01/22 23/02/23 20/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,275 2,538 2,486 2,301 2,348 2,853 2,795 2,723 2,569 2,611 2,777 2,840 2,700 2,823 3,018
EBITDA 1 745 813 744 607 453 596 616 624 608 583 680.9 737.9 708.2 703.1 763.1
EBIT 1 652 713 646 510 302 424 444 451 434 407 493 555.2 530.7 528.2 588.2
Operating Margin 28.66% 28.09% 25.99% 22.16% 12.86% 14.86% 15.89% 16.56% 16.89% 15.59% 17.76% 19.55% 19.65% 18.71% 19.49%
Earnings before Tax (EBT) 1 557 616 554 321 -70 121 216 714 132 157 350 421 393.7 406 459
Net income 1 524 502 434 191 767 91 219 951 698 121 304.8 356.8 334 349.5 395.5
Net margin 23.03% 19.78% 17.46% 8.3% 32.67% 3.19% 7.84% 34.92% 27.17% 4.63% 10.97% 12.56% 12.37% 12.38% 13.1%
EPS 2 4.790 4.610 3.980 1.750 7.030 0.8300 2.000 8.690 6.370 1.100 2.752 3.274 3.089 3.200 3.625
Dividend per Share 2 0.6800 0.6800 0.6800 0.6800 0.7000 0.7000 0.7000 - 0.7000 - 0.7083 0.7083 0.7200 0.7167 0.7233
Announcement Date 27/01/22 28/04/22 28/07/22 03/11/22 23/02/23 09/05/23 07/08/23 06/11/23 20/02/24 08/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,442 2,768 3,431 13,171 11,879 10,998 9,588 8,352
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.907 x 1.877 x 1.21 x 5.033 x 4.86 x 4.057 x 3.227 x 2.702 x
Free Cash Flow 1 1,084 979 1,290 1,276 1,320 1,290 1,527 1,778
ROE (net income / shareholders' equity) 43.3% 30% 52.7% 35.3% 15.3% 16.4% 17.8% 17.7%
ROA (Net income/ Total Assets) 9.07% 19.5% 16.5% 9.07% 3.69% 4.7% 5.67% 6.28%
Assets 1 9,395 10,193 11,442 20,888 53,086 24,116 26,281 23,824
Book Value Per Share 2 20.80 29.90 38.80 52.00 64.80 72.60 82.20 93.40
Cash Flow per Share 2 11.70 11.30 15.70 16.70 17.40 14.70 18.40 21.60
Capex 1 370 364 467 543 568 442 496 540
Capex / Sales 5.88% 6.44% 5.47% 5.61% 5.19% 4.04% 4.28% 4.45%
Announcement Date 30/01/20 28/01/21 27/01/22 23/02/23 20/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
139.4 USD
Average target price
166 USD
Spread / Average Target
+19.06%
Consensus
  1. Stock Market
  2. Equities
  3. CE Stock
  4. Financials Celanese Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW